{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpsychedelic-spotlight.simplecast.com%2Fepisodes%2Fdoug-drysdale-cybin-KYX_xslF","width":444,"version":"1.0","type":"rich","title":"Doug Drysdale, CEO, Cybin","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/bebecc7d-bab7-47e7-be66-437a184e067d/2b4f0478-ed94-4e4c-879e-3c66dc51ac2a/ig-doug-drysdale-cybin2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/9e15c6f8-ff9d-48cc-9bef-e9e2f846fbd0\" height=\"200\" width=\"100%\" title=\"Doug Drysdale, CEO, Cybin\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Cybin’s CEO, Doug Drysdale, shares update on sublingual psilocybin treatment for depression, and more."}